Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine von van Andel, L., Zhang, Z., Lu, S., Kansra, V., Agarwal, S., Hughes, L., Tibben, M.M., Gebretensae, A., Rosing, H., Schellens, J.H.M., Beijnen, J.H.

Volltext

Characterization of Absorption, Metabolism, and Elimination of Niraparib, an Investigational Poly (ADP-Ribose) Polymerase Inhibitor, in Cancer Patients von Zhang, Z.-Y, Kansra, V, van Andel, L, Tibben, M.M, Rosing, H, Lu, S, Agarwal, S, Hughes, L, Schellens, J.H.M, Beijnen, J.H

Volltext

Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients von Aviles, P, Altares, R, van Andel, L, Lubomirov, R, Fudio, S, Rosing, H, Márquez Del Pino, F M, Tibben, M M, Benedit, G, Nan-Offeringa, L, Luepke Estefan, X E, Francesch, A, Zeaiter, A, Cuevas, C, Schellens, J H M, Beijnen, J H

Volltext

Liquid chromatography-tandem mass spectrometric assay for the quantification of galunisertib in human plasma and the application in a pre-clinical study von Tibben, M.M., Huijberts, S., Li, W., Schinkel, A.H., Gebretensae, A., Rosing, H., Beijnen, J.H.

Volltext

Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of lurbinectedin in human plasma and urine von van Andel, L., Rosing, H., Lubomirov, R., Avilés, P., Fudio, S., Tibben, M.M., Nan-Offeringa, L., Schellens, J.H.M., Beijnen, J.H.

Volltext

Liquid chromatography-tandem mass spectrometry assay to quantify plitidepsin in human plasma, whole blood and urine von van Andel, L., Rosing, H., Fudio, S., Avilés, P., Tibben, M.M., Gebretensae, A., Schellens, J.H.M., Beijnen, J.H.

Volltext

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin von Huitema, A. D. R., Spaander, M., Mathôt, R. A. A., Tibben, M. M., Holtkamp, M. J., Beijnen, J. H., Rodenhuis, S.

Volltext

Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry von CRUL, M, VAN DEN BONGARD, H. J. G. D, TIBBEN, M. M, VAN TELLINGEN, O, SAVA, G, SCHELLENS, J. H. M, BEIJNEN, J. H

Volltext